The Beacon H. Jack West, MD
-
- Health & Fitness
-
Dr. Jack West reviews emerging new information and controversial topics in health care in general, cancer treatment in particular.
-
- video
We're Removing The West Wind Podcast Video Feed - Now Watch on YouTube & BeaconMedIC.com
We're removing the West Wind Podcast video feed. You can still watch the podcast in video format on our YouTube channel (/BeaconMedIC) or at the BeaconMedIC.com website. Thanks!
-
- video
Dr. Hossein Borghaei (Pt 2): Reflecting on Progress & Future Directions in Immunotherapy
Drs. Hossein Borghaei and host Jack West discuss long term outcomes in lung cancer with immunotherapy, potential utility of IO combinations, and when we can consider patients doing well on immunotherapy as cured if doing well beyond 5 years.
-
- video
Dr. Hossein Borghaei (Pt 1): On His Own at 16, Journey from Tehran to Philadelphia
Dr. Hossein Borghaei sits with Dr. Jack West and traces his difficult journey from war-torn Iran to Germary and then the US, which he made alone as a 16 year-old before having the opportunity to pursue medicine & his career in thoracic oncology.
-
- video
Dr. Gideon Blumenthal (Pt 2): Working to Balance Access, Efficacy, and Safety at the FDA
Dr. West questions Dr. Gideon Blumenthal of the FDA about how he and his team there struggle to provide timely access to emerging cancer treatments, while also debating questions of the proper thresholds for efficacy and safety.
-
- video
Dr. Gideon Blumenthal (Pt 1): The Journey into Working for the FDA on Cancer Treatment Regulation
Drs. Gideon Blumenthal & Jack West discuss his early career interests and trajectory from medical oncology training at the NIH to joining the Federal Drug Administration (FDA) to regulate oncology drugs.
-
- video
Dr. Jack West on New Data Combining Radiation with Immunotherapy in Advanced NSCLC: A Brief Critical Review
Dr. Jack West provides a brief summary of key findings & limitations of two new papers just out in JAMA Oncology (Theelen et al & Bauml et al.) that evaluate the potential benefit of preceding immunotherapy with radiation in patients with advanced NSCLC.